Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine ?-Reference-Cited by-同舟云学术

Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine ?

Published:1996-10 Issue:2 Volume:67 Page:355-359
ISSN:0304-3959
Container-title:Pain
language:en
Short-container-title:

Author:

Goadsby Peter J.,Hoskin Karen L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine,Clinical Neurology,Neurology

Reference34 articles.

1. Subcutaneous sumatriptan during the migraine aura;Bates;Neurology,1994

2. Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion;Buzzi;Neuropharmacology,1991

3. A multicentre, double-blind, placebo-controlled, dose-range finding study to investigate the efficacy and safety of oral doses of 311C90 in the acute treatment of migraine;Dahlof;Headache,1995

4. The tentorial nerves and localisation of intracranial pain in man;Feindel;Neurology,1960

5. Treatment of migraine attacks with sumatriptan;Ferrari;N. Engl. J. Med.,1991

Cited by 171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurophysiological and Vascular Mechanisms of Action of Serotoninergic Drugs for Abortive Migraine Treatment;Neuroscience and Behavioral Physiology;2024-06

2. Neurophysiological and Vascular Mechanisms of Action of the Serotoninergic Drugs for Abortive Migraine Treatment;Успехи физиологических наук;2023-07-01

3. Migraine: from pathophysiology to treatment;Journal of Neurology;2023-04-08

4. KCl-induced repetitive cortical spreading depression inhibiting trigeminal neuronal firing is mediated by 5-HT_1B/1D and opioid receptors;Cephalalgia;2022-07-13

5. Systematic review of drugs that modify the circadian system’s phase-shifting responses to light exposure;Neuropsychopharmacology;2021-12-27